Amazon cover image
Image from Amazon.com

Cardiotoxicity of chemotherapeutic agents / Gregg M. Lanier, Jalaj Garg and Neeraj Shah, editors.

Contributor(s): Material type: TextTextPublisher: New York : Nova Science Publishers, 2017Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781536121353
  • 1536121355
Subject(s): Genre/Form: DDC classification:
  • 616.12 23
LOC classification:
  • RC667
Online resources:
Contents:
Preface; Chapter 1; Introduction: Cardiotoxicity of Chemotherapeutic Agents; Introduction; References; Chapter 2; Alkylating Agents; Cyclophosphamide; Ifosphamide (IFS); Carboplatin; Busulfan; Altretamine (Hexalen); Procarbazine; References; Chapter 3; Antimetabolites; 5-Fluorouracil; Raltitrexed (Tomudex); Cytosine Arabinoside (Cytarabine or Ara-C); Gemcitabine; Pentostatin; Other Antimetabolites; References; Chapter 4; Antitumor Antibiotics: Bleomycin and Mitoxantrone; Bleomycin; Mitoxantrone; References; Chapter 5
I. Electrocardiogram (EGC) Changes and Arrhythmias Associated with Anthracycline Useii. Chronic Cardiomyopathy; iii. Sub-Clinical Cardiotoxicity; Risk Factors Associated with Poor Long-Term Cardiovascular Outcomes; References; Chapter 7; Antitumor Antibiotics: Anthracyclines and Minimizing Cardiotoxicity; Approaches to Minimize Anthracycline Cardiotoxicity; 1. Pharmacokinetic Approaches for Cardiac Prevention; 2. Pharmacogenetic Approaches for Cardiac Prevention; 3. Chemo Protectants and Adjunctive Therapies to Reduce Cardiotoxicity; References; Chapter 8
Antitumor Antibiotics: Newer AnthracyclinesNew Anthracyclines; References; Chapter 9; Microtubule Inhibitors; Microtubule Inhibitors; Paclitaxel; Docetaxel; Vinca Alkaloids; Eribulin; Ixabepilone; References; Chapter 10; Hormonal Therapy; Estrogens; Aromatase Inhibitors; Progestins; Tamoxifen; Androgen Deprivation Therapy; Flutamide; Leuprolide; Cyproterone Acetate; References; Chapter 11; Immunotherapy; Interleukin; Interferon; References; Chapter 12; Monoclonal Antibodies; Trastuzumab; Rituximab; Alemtuzumab; Bevacizumab; Cetuximab; Gemtuzumab; Ibritumomab; Tositumomab; References
Chapter 13Tyrosine Kinase Inhibitors; Imatinib; Dasatinib; Nilotinib; Sunitinib; Sorafenib; Lapatinib; Erlotinib and Geftinib; Other Tyrosine Kinase Inhibitors; References; Chapter 14; Topoisomerase-1 Inhibitors and Miscellaneous Drugs; Topoisomerase-1 Inhibitors; Irinotecan (CAMPTOSAR) and Topotecan (Hycamtin); Other Miscellaneous Drugs; Tretinoin; Arsenic Trioxide (Trisenox); References; About the Editors; Index; Blank Page
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Collection Call number Materials specified Status Date due Barcode
Electronic-Books Electronic-Books OPJGU Sonepat- Campus E-Books EBSCO Available

Online resource; title from PDF title page (EBSCO, viewed June 27, 2017)

Includes bibliographical references and index.

Preface; Chapter 1; Introduction: Cardiotoxicity of Chemotherapeutic Agents; Introduction; References; Chapter 2; Alkylating Agents; Cyclophosphamide; Ifosphamide (IFS); Carboplatin; Busulfan; Altretamine (Hexalen); Procarbazine; References; Chapter 3; Antimetabolites; 5-Fluorouracil; Raltitrexed (Tomudex); Cytosine Arabinoside (Cytarabine or Ara-C); Gemcitabine; Pentostatin; Other Antimetabolites; References; Chapter 4; Antitumor Antibiotics: Bleomycin and Mitoxantrone; Bleomycin; Mitoxantrone; References; Chapter 5

I. Electrocardiogram (EGC) Changes and Arrhythmias Associated with Anthracycline Useii. Chronic Cardiomyopathy; iii. Sub-Clinical Cardiotoxicity; Risk Factors Associated with Poor Long-Term Cardiovascular Outcomes; References; Chapter 7; Antitumor Antibiotics: Anthracyclines and Minimizing Cardiotoxicity; Approaches to Minimize Anthracycline Cardiotoxicity; 1. Pharmacokinetic Approaches for Cardiac Prevention; 2. Pharmacogenetic Approaches for Cardiac Prevention; 3. Chemo Protectants and Adjunctive Therapies to Reduce Cardiotoxicity; References; Chapter 8

Antitumor Antibiotics: Newer AnthracyclinesNew Anthracyclines; References; Chapter 9; Microtubule Inhibitors; Microtubule Inhibitors; Paclitaxel; Docetaxel; Vinca Alkaloids; Eribulin; Ixabepilone; References; Chapter 10; Hormonal Therapy; Estrogens; Aromatase Inhibitors; Progestins; Tamoxifen; Androgen Deprivation Therapy; Flutamide; Leuprolide; Cyproterone Acetate; References; Chapter 11; Immunotherapy; Interleukin; Interferon; References; Chapter 12; Monoclonal Antibodies; Trastuzumab; Rituximab; Alemtuzumab; Bevacizumab; Cetuximab; Gemtuzumab; Ibritumomab; Tositumomab; References

Chapter 13Tyrosine Kinase Inhibitors; Imatinib; Dasatinib; Nilotinib; Sunitinib; Sorafenib; Lapatinib; Erlotinib and Geftinib; Other Tyrosine Kinase Inhibitors; References; Chapter 14; Topoisomerase-1 Inhibitors and Miscellaneous Drugs; Topoisomerase-1 Inhibitors; Irinotecan (CAMPTOSAR) and Topotecan (Hycamtin); Other Miscellaneous Drugs; Tretinoin; Arsenic Trioxide (Trisenox); References; About the Editors; Index; Blank Page

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide

There are no comments on this title.

to post a comment.

O.P. Jindal Global University, Sonepat-Narela Road, Sonepat, Haryana (India) - 131001

Send your feedback to glus@jgu.edu.in

Hosted, Implemented & Customized by: BestBookBuddies   |   Maintained by: Global Library